Dmitry Chudakov

Biography

Dmitry Chudakov studied at the Lomonosov Moscow State University (MSU). Since 2000 Dr Chudakov has been working at the Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (IBCH RAS), where he received his PhD and Doctor of Science degrees in 2003 and 2011, respectively.  In 2008 he became Head of the Laboratory of Genomics of Adaptive Immunity in IBCH RAS. Since 2013, Dmitry has also held a position of Head of the Research group Adaptive Immunity at Central European Institute of Technology in the Czech Republic. In addition he worked at Evrogen JSC (a well-known Russian biotechnology company), and in 2016 he founded MiLaboratory LLC company that is currently a Skolkovo Innovation Center resident. Dmitry’s research and innovation activities include, among others, development of molecular tools for the basic and biomedical studies, as well development of new methods to identify PCR and sequencing errors and analyze high-throughput sequencing data. His current focus of interest is the role of clonal T cell and B cell populations in autoimmunity and cancer, DNA technologies and software development for the quantitative analysis of individual T cell receptor and antibody repertoires in health and disease. Dr Chudakov participated in more than 50 international conferences in more than 10 countries, mostly as a speaker. He is a holder of several patents, an author of >90 publications in peer reviewed journals, and is currently one of the most cited young biologists in Russia (h = 34). Dmitry was awarded with a number of prestigious prizes including the Presidential Prize in Science and Innovation for Young Scientists (2013). In 2016 he was awarded the title of Professor of Russian Academy of Sciences in Biology.

Research Interest

Dmitry’s research and innovation activities include, among others, development of molecular tools for the basic and biomedical studies, as well development of new methods to identify PCR and sequencing errors and analyze high-throughput sequencing data. His current focus of interest is the role of clonal T cell and B cell populations in autoimmunity and cancer, DNA technologies and software development for the quantitative analysis of individual T cell receptor and antibody repertoires in health and disease.